Gene Delivery System Industry Research Report 2023
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Highlights
The global Gene Delivery System market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.
North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.
Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery System.
The Gene Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gene Delivery System market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Gene Delivery System type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Gene Delivery System are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Gene Delivery System segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Gene Delivery System market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Gene Delivery System market.
Gene Delivery System Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Gene Delivery System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Gene Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Gene Delivery System industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Delivery System.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global Gene Delivery System market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.
North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.
Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery System.
The Gene Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gene Delivery System market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
Global markets are presented by Gene Delivery System type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Gene Delivery System are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Gene Delivery System segment by Type
- Viral Gene Delivery System
- Non-viral Gene Delivery System
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Gene Delivery System market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Gene Delivery System market.
Gene Delivery System Segment by Application
- Neurological Diseases
- Cancer
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Gene Delivery System market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Gene Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Gene Delivery System industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Delivery System.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
- What factors will challenge the Product Name market growth?
- Which end-use segment will expand at the fastest CAGR in the Product Name market?
- Which are the emerging players in the Product Name market?
- How concentrated is the Product Name market?
- Which factors are positively contributing to the Product Name market growth?
- Which are the novel product innovations in the Product Name market?
- Which product segment will emerge as the most lucrative in the Product Name market?
- Which factors are increasing the competition in the Product Name market?
- Which are the strategic measures taken by the Product Name industry players?
- Which region will witness inactive growth during the forecast period?
- What key trends are likely to emerge in the Product Name market in the coming years?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Gene Delivery System Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Gene Delivery System Revenue Market Share by Type (2018-2023)
Table 7. Global Gene Delivery System Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Gene Delivery System Revenue Market Share by Type (2024-2029)
Table 9. Global Gene Delivery System Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Gene Delivery System Revenue Market Share by Application (2018-2023)
Table 11. Global Gene Delivery System Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Gene Delivery System Revenue Market Share by Application (2024-2029)
Table 13. Global Gene Delivery System Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Gene Delivery System Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Gene Delivery System Market Share by Region (2018-2023)
Table 16. Global Gene Delivery System Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Gene Delivery System Market Share by Region (2024-2029)
Table 18. Gene Delivery System Market Trends
Table 19. Gene Delivery System Market Drivers
Table 20. Gene Delivery System Market Challenges
Table 21. Gene Delivery System Market Restraints
Table 22. Global Top Gene Delivery System Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Gene Delivery System Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Gene Delivery System Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Gene Delivery System, Headquarters and Area Served
Table 26. Global Gene Delivery System Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Gene Delivery System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Gene Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Gene Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Gene Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Gene Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Gene Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Gene Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Gene Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Gene Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Gene Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Gene Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 45. Biogen Company Detail
Table 46. Biogen Business Overview
Table 47. Biogen Gene Delivery System Product
Table 48. Biogen Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 49. Biogen Recent Development
Table 50. Novartis Company Detail
Table 51. Novartis Business Overview
Table 52. Novartis Gene Delivery System Product
Table 53. Novartis Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Gilead Sciences Company Detail
Table 56. Gilead Sciences Business Overview
Table 57. Gilead Sciences Gene Delivery System Product
Table 58. Gilead Sciences Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 59. Gilead Sciences Recent Development
Table 60. Sarepta Therapeutics Company Detail
Table 61. Sarepta Therapeutics Business Overview
Table 62. Sarepta Therapeutics Gene Delivery System Product
Table 63. Sarepta Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 64. Sarepta Therapeutics Recent Development
Table 65. Alnylam Pharmaceuticals Company Detail
Table 66. Alnylam Pharmaceuticals Business Overview
Table 67. Alnylam Pharmaceuticals Gene Delivery System Product
Table 68. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 69. Alnylam Pharmaceuticals Recent Development
Table 70. Amgen Company Detail
Table 71. Amgen Business Overview
Table 72. Amgen Gene Delivery System Product
Table 73. Amgen Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 74. Amgen Recent Development
Table 75. Spark Therapeutics Company Detail
Table 76. Spark Therapeutics Business Overview
Table 77. Spark Therapeutics Gene Delivery System Product
Table 78. Spark Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 79. Spark Therapeutics Recent Development
Table 80. Akcea Therapeutics Company Detail
Table 81. Akcea Therapeutics Business Overview
Table 82. Akcea Therapeutics Gene Delivery System Product
Table 83. Akcea Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 84. Akcea Therapeutics Recent Development
Table 85. bluebird bio Company Detail
Table 86. bluebird bio Business Overview
Table 87. bluebird bio Gene Delivery System Product
Table 88. bluebird bio Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 89. bluebird bio Recent Development
Table 90. Sunway Biotech Company Detail
Table 91. Sunway Biotech Business Overview
Table 92. Sunway Biotech Gene Delivery System Product
Table 93. Sunway Biotech Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 94. Sunway Biotech Recent Development
Table 95. SIBIONO Company Detail
Table 96. SIBIONO Business Overview
Table 97. SIBIONO Gene Delivery SystemProduct
Table 98. SIBIONO Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 99. SIBIONO Recent Development
Table 100. AnGes Company Detail
Table 101. AnGes Business Overview
Table 102. AnGes Gene Delivery SystemProduct
Table 103. AnGes Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 104. AnGes Recent Development
Table 105. Orchard Therapeutics Company Detail
Table 106. Orchard Therapeutics Business Overview
Table 107. Orchard Therapeutics Gene Delivery SystemProduct
Table 108. Orchard Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 109. Orchard Therapeutics Recent Development
Table 110. Human Stem Cells Institute Company Detail
Table 111. Human Stem Cells Institute Business Overview
Table 112. Human Stem Cells Institute Gene Delivery SystemProduct
Table 113. Human Stem Cells Institute Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 114. Human Stem Cells Institute Recent Development
Table 115. Biogen Company Information
Table 116. Biogen Business Overview
Table 117. Biogen Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 118. Biogen Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 119. Biogen Recent Development
Table 120. Novartis Company Information
Table 121. Novartis Business Overview
Table 122. Novartis Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 123. Novartis Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 124. Novartis Recent Development
Table 125. Gilead Sciences Company Information
Table 126. Gilead Sciences Business Overview
Table 127. Gilead Sciences Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 128. Gilead Sciences Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 129. Gilead Sciences Recent Development
Table 130. Sarepta Therapeutics Company Information
Table 131. Sarepta Therapeutics Business Overview
Table 132. Sarepta Therapeutics Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 133. Sarepta Therapeutics Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 134. Sarepta Therapeutics Recent Development
Table 135. Alnylam Pharmaceuticals Company Information
Table 136. Alnylam Pharmaceuticals Business Overview
Table 137. Alnylam Pharmaceuticals Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 138. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 139. Alnylam Pharmaceuticals Recent Development
Table 140. Amgen Company Information
Table 141. Amgen Business Overview
Table 142. Amgen Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 143. Amgen Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 144. Amgen Recent Development
Table 145. Spark Therapeutics Company Information
Table 146. Spark Therapeutics Business Overview
Table 147. Spark Therapeutics Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 148. Spark Therapeutics Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 149. Spark Therapeutics Recent Development
Table 150. Akcea Therapeutics Company Information
Table 151. Akcea Therapeutics Business Overview
Table 152. Akcea Therapeutics Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 153. Akcea Therapeutics Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 154. Akcea Therapeutics Recent Development
Table 155. bluebird bio Company Information
Table 156. bluebird bio Business Overview
Table 157. bluebird bio Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 158. bluebird bio Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 159. bluebird bio Recent Development
Table 160. Sunway Biotech Company Information
Table 161. Sunway Biotech Business Overview
Table 162. Sunway Biotech Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 163. Sunway Biotech Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 164. Sunway Biotech Recent Development
Table 165. SIBIONO Company Information
Table 166. SIBIONO Business Overview
Table 167. SIBIONO Gene Delivery SystemRevenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 168. SIBIONO Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 169. SIBIONO Recent Development
Table 170. AnGes Company Information
Table 171. AnGes Business Overview
Table 172. AnGes Gene Delivery SystemRevenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 173. AnGes Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 174. AnGes Recent Development
Table 175. Orchard Therapeutics Company Information
Table 176. Orchard Therapeutics Business Overview
Table 177. Orchard Therapeutics Gene Delivery SystemRevenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 178. Orchard Therapeutics Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 179. Orchard Therapeutics Recent Development
Table 180. Human Stem Cells Institute Company Information
Table 181. Human Stem Cells Institute Business Overview
Table 182. Human Stem Cells Institute Gene Delivery SystemRevenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 183. Human Stem Cells Institute Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 184. Human Stem Cells Institute Recent Development
Table 185. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Gene Delivery System Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Gene Delivery System Revenue Market Share by Type (2018-2023)
Table 7. Global Gene Delivery System Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Gene Delivery System Revenue Market Share by Type (2024-2029)
Table 9. Global Gene Delivery System Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Gene Delivery System Revenue Market Share by Application (2018-2023)
Table 11. Global Gene Delivery System Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Gene Delivery System Revenue Market Share by Application (2024-2029)
Table 13. Global Gene Delivery System Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Gene Delivery System Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Gene Delivery System Market Share by Region (2018-2023)
Table 16. Global Gene Delivery System Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Gene Delivery System Market Share by Region (2024-2029)
Table 18. Gene Delivery System Market Trends
Table 19. Gene Delivery System Market Drivers
Table 20. Gene Delivery System Market Challenges
Table 21. Gene Delivery System Market Restraints
Table 22. Global Top Gene Delivery System Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Gene Delivery System Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Gene Delivery System Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Gene Delivery System, Headquarters and Area Served
Table 26. Global Gene Delivery System Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Gene Delivery System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Gene Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Gene Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Gene Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Gene Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Gene Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Gene Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Gene Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Gene Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Gene Delivery System Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Gene Delivery System Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Gene Delivery System Market Size by Country (2024-2029) & (US$ Million)
Table 45. Biogen Company Detail
Table 46. Biogen Business Overview
Table 47. Biogen Gene Delivery System Product
Table 48. Biogen Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 49. Biogen Recent Development
Table 50. Novartis Company Detail
Table 51. Novartis Business Overview
Table 52. Novartis Gene Delivery System Product
Table 53. Novartis Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Gilead Sciences Company Detail
Table 56. Gilead Sciences Business Overview
Table 57. Gilead Sciences Gene Delivery System Product
Table 58. Gilead Sciences Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 59. Gilead Sciences Recent Development
Table 60. Sarepta Therapeutics Company Detail
Table 61. Sarepta Therapeutics Business Overview
Table 62. Sarepta Therapeutics Gene Delivery System Product
Table 63. Sarepta Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 64. Sarepta Therapeutics Recent Development
Table 65. Alnylam Pharmaceuticals Company Detail
Table 66. Alnylam Pharmaceuticals Business Overview
Table 67. Alnylam Pharmaceuticals Gene Delivery System Product
Table 68. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 69. Alnylam Pharmaceuticals Recent Development
Table 70. Amgen Company Detail
Table 71. Amgen Business Overview
Table 72. Amgen Gene Delivery System Product
Table 73. Amgen Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 74. Amgen Recent Development
Table 75. Spark Therapeutics Company Detail
Table 76. Spark Therapeutics Business Overview
Table 77. Spark Therapeutics Gene Delivery System Product
Table 78. Spark Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 79. Spark Therapeutics Recent Development
Table 80. Akcea Therapeutics Company Detail
Table 81. Akcea Therapeutics Business Overview
Table 82. Akcea Therapeutics Gene Delivery System Product
Table 83. Akcea Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 84. Akcea Therapeutics Recent Development
Table 85. bluebird bio Company Detail
Table 86. bluebird bio Business Overview
Table 87. bluebird bio Gene Delivery System Product
Table 88. bluebird bio Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 89. bluebird bio Recent Development
Table 90. Sunway Biotech Company Detail
Table 91. Sunway Biotech Business Overview
Table 92. Sunway Biotech Gene Delivery System Product
Table 93. Sunway Biotech Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 94. Sunway Biotech Recent Development
Table 95. SIBIONO Company Detail
Table 96. SIBIONO Business Overview
Table 97. SIBIONO Gene Delivery SystemProduct
Table 98. SIBIONO Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 99. SIBIONO Recent Development
Table 100. AnGes Company Detail
Table 101. AnGes Business Overview
Table 102. AnGes Gene Delivery SystemProduct
Table 103. AnGes Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 104. AnGes Recent Development
Table 105. Orchard Therapeutics Company Detail
Table 106. Orchard Therapeutics Business Overview
Table 107. Orchard Therapeutics Gene Delivery SystemProduct
Table 108. Orchard Therapeutics Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 109. Orchard Therapeutics Recent Development
Table 110. Human Stem Cells Institute Company Detail
Table 111. Human Stem Cells Institute Business Overview
Table 112. Human Stem Cells Institute Gene Delivery SystemProduct
Table 113. Human Stem Cells Institute Revenue in Gene Delivery System Business (2017-2022) & (US$ Million)
Table 114. Human Stem Cells Institute Recent Development
Table 115. Biogen Company Information
Table 116. Biogen Business Overview
Table 117. Biogen Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 118. Biogen Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 119. Biogen Recent Development
Table 120. Novartis Company Information
Table 121. Novartis Business Overview
Table 122. Novartis Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 123. Novartis Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 124. Novartis Recent Development
Table 125. Gilead Sciences Company Information
Table 126. Gilead Sciences Business Overview
Table 127. Gilead Sciences Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 128. Gilead Sciences Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 129. Gilead Sciences Recent Development
Table 130. Sarepta Therapeutics Company Information
Table 131. Sarepta Therapeutics Business Overview
Table 132. Sarepta Therapeutics Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 133. Sarepta Therapeutics Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 134. Sarepta Therapeutics Recent Development
Table 135. Alnylam Pharmaceuticals Company Information
Table 136. Alnylam Pharmaceuticals Business Overview
Table 137. Alnylam Pharmaceuticals Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 138. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 139. Alnylam Pharmaceuticals Recent Development
Table 140. Amgen Company Information
Table 141. Amgen Business Overview
Table 142. Amgen Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 143. Amgen Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 144. Amgen Recent Development
Table 145. Spark Therapeutics Company Information
Table 146. Spark Therapeutics Business Overview
Table 147. Spark Therapeutics Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 148. Spark Therapeutics Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 149. Spark Therapeutics Recent Development
Table 150. Akcea Therapeutics Company Information
Table 151. Akcea Therapeutics Business Overview
Table 152. Akcea Therapeutics Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 153. Akcea Therapeutics Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 154. Akcea Therapeutics Recent Development
Table 155. bluebird bio Company Information
Table 156. bluebird bio Business Overview
Table 157. bluebird bio Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 158. bluebird bio Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 159. bluebird bio Recent Development
Table 160. Sunway Biotech Company Information
Table 161. Sunway Biotech Business Overview
Table 162. Sunway Biotech Gene Delivery System Revenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 163. Sunway Biotech Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 164. Sunway Biotech Recent Development
Table 165. SIBIONO Company Information
Table 166. SIBIONO Business Overview
Table 167. SIBIONO Gene Delivery SystemRevenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 168. SIBIONO Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 169. SIBIONO Recent Development
Table 170. AnGes Company Information
Table 171. AnGes Business Overview
Table 172. AnGes Gene Delivery SystemRevenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 173. AnGes Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 174. AnGes Recent Development
Table 175. Orchard Therapeutics Company Information
Table 176. Orchard Therapeutics Business Overview
Table 177. Orchard Therapeutics Gene Delivery SystemRevenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 178. Orchard Therapeutics Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 179. Orchard Therapeutics Recent Development
Table 180. Human Stem Cells Institute Company Information
Table 181. Human Stem Cells Institute Business Overview
Table 182. Human Stem Cells Institute Gene Delivery SystemRevenue in Gene Delivery System Business (2018-2023) & (US$ Million)
Table 183. Human Stem Cells Institute Revenue in Gene Delivery System Business (2018-2023) & (US$ Million) Portfolio
Table 184. Human Stem Cells Institute Recent Development
Table 185. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Gene Delivery System Product Picture
Figure 5. Global Gene Delivery System Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Gene Delivery System Market Share by Type: 2022 VS 2029
Figure 7. Viral Gene Delivery System Product Picture
Figure 8. Non-viral Gene Delivery System Product Picture
Figure 9. Global Gene Delivery System Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Gene Delivery System Market Share by Application: 2022 VS 2029
Figure 11. Neurological Diseases Product Picture
Figure 12. Cancer Product Picture
Figure 13. Others Product Picture
Figure 14. Global Gene Delivery System Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Gene Delivery System Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Gene Delivery System Market Share by Region: 2022 VS 2029
Figure 17. Global Gene Delivery System Market Share by Players in 2022
Figure 18. Global Gene Delivery System Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Gene Delivery System Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Gene Delivery System Market Share by Country (2018-2029)
Figure 23. United States Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Gene Delivery System Market Share by Country (2018-2029)
Figure 27. Germany Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Gene Delivery System Market Share by Country (2018-2029)
Figure 35. China Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Gene Delivery System Market Share by Country (2018-2029)
Figure 43. Mexico Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Gene Delivery System Market Share by Country (2018-2029)
Figure 47. Turkey Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Biogen Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 52. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 53. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 54. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 55. Amgen Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 56. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 57. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 58. bluebird bio Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 59. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 60. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 61. AnGes Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 62. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 63. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Gene Delivery System Product Picture
Figure 5. Global Gene Delivery System Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Gene Delivery System Market Share by Type: 2022 VS 2029
Figure 7. Viral Gene Delivery System Product Picture
Figure 8. Non-viral Gene Delivery System Product Picture
Figure 9. Global Gene Delivery System Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Gene Delivery System Market Share by Application: 2022 VS 2029
Figure 11. Neurological Diseases Product Picture
Figure 12. Cancer Product Picture
Figure 13. Others Product Picture
Figure 14. Global Gene Delivery System Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Gene Delivery System Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Gene Delivery System Market Share by Region: 2022 VS 2029
Figure 17. Global Gene Delivery System Market Share by Players in 2022
Figure 18. Global Gene Delivery System Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Gene Delivery System Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Gene Delivery System Market Share by Country (2018-2029)
Figure 23. United States Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Gene Delivery System Market Share by Country (2018-2029)
Figure 27. Germany Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Gene Delivery System Market Share by Country (2018-2029)
Figure 35. China Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Gene Delivery System Market Share by Country (2018-2029)
Figure 43. Mexico Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Gene Delivery System Market Share by Country (2018-2029)
Figure 47. Turkey Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE Gene Delivery System Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Biogen Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 52. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 53. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 54. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 55. Amgen Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 56. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 57. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 58. bluebird bio Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 59. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 60. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 61. AnGes Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 62. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2018-2023)
Figure 63. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2018-2023)
